Literature DB >> 12805164

Should drug companies be allowed to talk directly to patients? NO.

Wendy Garlick1.   

Abstract

Entities:  

Keywords:  Health Care and Public Health; Professional Patient Relationship

Mesh:

Year:  2003        PMID: 12805164      PMCID: PMC1126189          DOI: 10.1136/bmj.326.7402.1302-a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Bayer decides to withdraw cholesterol lowering drug.

Authors:  F Charatan
Journal:  BMJ       Date:  2001-08-18

2.  US consumer groups allege misleading drug claims.

Authors:  S Gottlieb
Journal:  BMJ       Date:  2001-08-25

3.  Yasmin advert withdrawn--why and how.

Authors: 
Journal:  Drug Ther Bull       Date:  2003-03

4.  Two advertisements for TV drug ads.

Authors:  Thomas Bodenheimer
Journal:  Health Aff (Millwood)       Date:  2003 Jan-Jun       Impact factor: 6.301

  4 in total
  2 in total

1.  Industry funded patient information and the slippery slope to New Zealand.

Authors:  Les Toop; Dee Mangin
Journal:  BMJ       Date:  2007-10-06

2.  Quality and availability of consumer information on heart failure in Australia.

Authors:  Agnes I Vitry; Susan M Phillips; Susan J Semple
Journal:  BMC Health Serv Res       Date:  2008-12-12       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.